Cargando…
The possible prognostic role of histone deacetylase and transforming growth factor β/ Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study
Glioblastoma (GBM) is the most common and aggressive tumor of the central nervous system. Unfortunately, patients affected by this disease have a very poor prognosis, due to high level of invasiveness and resistance to standard therapies. Although the molecular profile of GBM has been extensively in...
Autores principales: | Sferra, Roberta, Pompili, Simona, Festuccia, Claudio, Marampon, Francesco, Gravina, Giovanni L., Ventura, Luca, Cesare, Ernesto Di, Cicchinelli, Sara, Gaudio, Eugenio, Vetuschi, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439439/ https://www.ncbi.nlm.nih.gov/pubmed/28735518 http://dx.doi.org/10.4081/ejh.2017.2732 |
Ejemplares similares
-
Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical study
por: Sferra, Roberta, et al.
Publicado: (2018) -
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
por: Marampon, Francesco, et al.
Publicado: (2015) -
Correction: Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
por: Marampon, Francesco, et al.
Publicado: (2016) -
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
por: Festuccia, Claudio, et al.
Publicado: (2018) -
Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
por: Festuccia, C., et al.
Publicado: (2018)